EyePoint sues Ocular Therapeutix, alleging misleading statements about experimental eye drug
EyePoint Pharmaceuticals has filed suit in Middlesex County Superior Court alleging that Ocular Therapeutix made false or misleading statements about EyePoint and its lead experimental therapy, Duravyu. The complaint seeks an injunction, a public retraction, and monetary damages, and follows competition between the companies developing longer-lasti…